Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy
Keywords: تمایز نوروندوکرین; Androgen deprivation therapy; Neuroendocrine differentiation; Prednisone; Prostate-specific antigen;